OM insider filings

Outset Medical, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen OM transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 3 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Leonard Braden Michael — 10% owner12 legs · 244,909 sh · $870,260——
Gaeta Renee — Chief Financial Officer1—1 leg · 4,498 sh · $16,508—
Trigg Leslie — Chair and CEO, Director1—1 leg · 3,403 sh · $12,489—

Recent insider filings — Outset Medical, Inc.

FiledFormInsiderReported transactionsSource
2026-11-174Gaeta Renee — Chief Financial OfficerSale (S): 4,498 @ $3.67EDGAR
2026-11-174Trigg Leslie — Chair and CEO, DirectorSale (S): 3,403 @ $3.67EDGAR
2026-10-054Leonard Braden Michael — 10% ownerPurchase (P): 228,334 @ $3.53 · Purchase (P): 16,575 @ $3.88EDGAR
2026-08-184Trigg Leslie — Chair and CEO, DirectorSale (S): 3,437 @ $4.39EDGAR
2026-08-184Brottem John L. — General CounselSale (S): 2,632 @ $4.39EDGAR
2026-08-184Gaeta Renee — Chief Financial OfficerSale (S): 4,543 @ $4.39EDGAR
2026-06-294Brottem John L. — General CounselGrant/award (A): 59,830 @ $0EDGAR
2026-06-294Gaeta Renee — Chief Financial OfficerGrant/award (A): 71,630 @ $0EDGAR
2026-06-294Trigg Leslie — Chair and CEO, DirectorGrant/award (A): 99,160 @ $0EDGAR
2026-06-054Prange Karen — DirectorGrant/award (A): 10,667 @ $0EDGAR
2026-06-054LANG BRENT D. — DirectorGrant/award (A): 10,667 @ $0EDGAR
2026-06-054Drexler Karen — DirectorGrant/award (A): 10,667 @ $0EDGAR
2026-06-054Gaeta Renee — Chief Financial OfficerSale (S): 17,672 @ $4.94EDGAR
2026-06-054HACKETT PATRICK T — DirectorGrant/award (A): 10,667 @ $0EDGAR
2026-06-054GROSSMAN D KEITH — DirectorGrant/award (A): 10,667 @ $0EDGAR
2026-06-054OBOYLE KEVIN C — DirectorGrant/award (A): 10,667 @ $0EDGAR
2026-05-194Nash Marc — EVP Operations R&D & ServiceSale (S): 1,582 @ $3.70EDGAR
2026-05-194Brottem John L. — General CounselSale (S): 2,638 @ $3.70EDGAR
2026-05-194Trigg Leslie — Chair and CEO, DirectorSale (S): 3,445 @ $3.70EDGAR
2026-05-184Leonard Braden Michael — 10% ownerOption exercise/expiry (X): 323,000 @ $5EDGAR
2026-05-124Leonard Braden Michael — 10% ownerOption exercise/expiry (X): 197,600 @ $5 · Option exercise/expiry (X): 96,900 @ $5EDGAR
2026-04-084Elliott Derick A. — EVP, CommercialGrant/award (A): 96,000 @ $0EDGAR
2026-02-194Nash Marc — EVP Operations R&D & ServiceSale (S): 1,817 @ $3.35EDGAR
2026-02-194Brottem John L. — General CounselSale (S): 2,842 @ $3.35EDGAR
2026-02-194Trigg Leslie — Chair and CEO, DirectorSale (S): 3,361 @ $3.35EDGAR
2026-01-214Nash Marc — EVP Operations R&D & ServiceSale (S): 5,375 @ $5.12 · Sale (S): 980 @ $4.98EDGAR
2026-01-214Brottem John L. — General CounselSale (S): 9,314 @ $5.12 · Sale (S): 1,180 @ $5.01EDGAR
2026-01-214Trigg Leslie — Chair and CEO, DirectorSale (S): 11,794 @ $5.12 · Sale (S): 2,120 @ $5.05EDGAR
2026-01-124Prange Karen — DirectorGrant/award (A): 18,667 @ $0EDGAR
2026-01-084Nash Marc — EVP Operations R&D & ServiceSale (S): 108 @ $4.27EDGAR
2026-01-084Brottem John L. — General CounselSale (S): 224 @ $4.27EDGAR
2026-01-084Trigg Leslie — Chair and CEO, DirectorSale (S): 1,795 @ $4.27EDGAR
2025-12-024Drexler Karen — DirectorSale (S): 1,548 @ $4.37EDGAR
2025-11-184Nash Marc — EVP Operations R&D & ServiceSale (S): 247 @ $4.60EDGAR
2025-11-184Brottem John L. — General CounselSale (S): 388 @ $4.60EDGAR
2025-11-184Trigg Leslie — Chair and CEO, DirectorSale (S): 916 @ $4.60EDGAR
2025-08-254Nash Marc — EVP, R&D, Operations and Serv.Grant/award (A): 5,617 @ $0EDGAR
2025-08-184Nash Marc — SVP Operations and R&DSale (S): 243 @ $12.88EDGAR
2025-08-184Brottem John L. — General CounselSale (S): 383 @ $12.88EDGAR
2025-08-184Trigg Leslie — Chair and CEO, DirectorSale (S): 904 @ $12.88EDGAR
2025-06-114Nash Marc — SVP Operations and R&DGrant/award (A): 29,676 @ $0EDGAR
2025-06-114Brottem John L. — General CounselGrant/award (A): 35,993 @ $0EDGAR
2025-06-114Gaeta Renee — Chief Financial OfficerGrant/award (A): 131,425 @ $0EDGAR
2025-06-114Trigg Leslie — Chair and CEO, DirectorGrant/award (A): 65,103 @ $0EDGAR
2025-06-044Saia Andrea Lynn — DirectorGrant/award (A): 8,983 @ $0EDGAR
2025-06-044LANG BRENT D. — DirectorGrant/award (A): 8,983 @ $0EDGAR
2025-06-044Drexler Karen — DirectorGrant/award (A): 8,983 @ $0EDGAR
2025-06-044HACKETT PATRICK T — DirectorGrant/award (A): 8,983 @ $0EDGAR
2025-06-044GROSSMAN D KEITH — DirectorGrant/award (A): 8,983 @ $0EDGAR
2025-06-044OBOYLE KEVIN C — DirectorGrant/award (A): 8,983 @ $0EDGAR

Recent 8-K events — Outset Medical, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-178-K1.01 — Entry into a Material Definitive Agreement
2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-298-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=OM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs